Pictet & Cie (Europe) Sa Abb Vie Inc. Transaction History

Pictet & Cie (Europe) Sa

$4.19 Billion
Q3 2024

A detailed history of Pictet & Cie (Europe) Sa transactions in Abb Vie Inc. stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 206,571 shares of ABBV stock, worth $36.3 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

206,571

Previous 196,581 5.08%

Holding current value

$36.3 Million

Previous $33.7 Million 20.99%

% of portfolio

0.97%

Previous 0.83%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$163.84 - $199.33 $1.64 Million - $1.99 Million	9,990 Added 5.08%	206,571 $40.8 Million
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $1.62 Million - $1.89 Million	10,476 Added 5.63%	196,581 $33.7 Million
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $7.37 Million - $8.4 Million	46,143 Added 32.97%	186,105 $33.9 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $605,440 - $681,868	4,400 Added 3.25%	139,962 $21.7 Million
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $6.28 Million - $7.27 Million	47,019 Added 53.1%	135,562 $20.2 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $254,286 - $316,443	1,919 Added 2.22%	88,543 $11.9 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $133,619 - $153,882	-924 Reduced 1.06%	86,624 $13.8 Million
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $10.3 Million - $12.4 Million	74,738 Added 583.43%	87,548 $0
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $1.3 Million - $1.49 Million	9,660 Added 306.67%	12,810 $1.72 Billion
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $11,009 - $13,996	-80 Reduced 2.48%	3,150 $482,000
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $330,429 - $363,762	3,230 New	3,230 $350,000
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $301,694 - $355,079	-3,911 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$77.85 - $96.01 $115,996 - $143,054	-1,490 Reduced 27.59%	3,911 $361,000
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $17,337 - $19,273	195 Added 3.75%	5,401 $511,000
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $17,507 - $20,714	195 Added 3.89%	5,206 $482,000
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $460 - $616	-5 Reduced 0.1%	5,011 $474,000
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $934,827 - $1.03 Million	-10,438 Reduced 67.54%	5,016 $485,000
Q2 2017 Aug 09, 2017	BUY	N/A	15,454	15,454 $1.12 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Abb Vie Inc. Transaction History